Navigation Links
Verum.de Exhibits at Outsourcing in Clinical Trials Southern California
Date:8/29/2013

SAN DIEGO, Aug. 29, 2013 /PRNewswire/ -- Verum.de, a full-clinical service, German-based contract research organization (CRO) with seven offices throughout Europe and a U.S. office in Carlsbad, Calif., will participate in the Outsourcing in Clinical Trials Southern California meeting in San Diego, Sept. 24-25, 2013. Verum will exhibit at booth #3 and will answer questions on conducting international clinical trials, logistics of study medication and bio samples (im- and exportation, packaging, distribution and storage) specifically in Central Eastern European (CEE) countries.

(Logo: http://photos.prnewswire.com/prnh/20120807/LA53176LOGO)  

Southern California is the newest location for the OCT series. This meeting brings together life science professionals interested in growth, innovation and latest trends of the industry, focused on topics relevant to pharma, biotech, and medical device companies. Attendees who visit the Verum booth will have the opportunity to meet Christian Sacher, CEO, Dagmar Siebold, European director of client relations, and US and European business development teams.

"We look forward to expanding our attendance in US industry events and to supporting the life sciences sector in Southern California where one of our offices is located," said Kristi Clark, president of Verum's U.S. office and operations. "With San Diego being one of the major hubs for pharma and biotech in the world, this exhibit will give us the opportunity to showcase our expertise to potential clients and partners interested in clinical trial services in CEE."

To set up an appointment or to learn more about Verum.de, contact Chuck Cade, VP, business development, US at cc@verum.us or call +1 (512) 917-8017.

About Verum.de
Verum has been the first Western-standard full-service CRO specializing in CEE/CIS countries, with key competency in full clinical service for Phases II-IV. Verum has successfully completed more than 130 clinical trials with about 40,000 patients for pharma, biotech and medical device companies as well as the US National Institutes of Health (NIH). The company's expertise covers cardiovascular, neurology, psychiatry, pain, oncology, and more. Operating since 1992, Verum is the strongest player in high recruiting CEE areas and maintains offices all over Eastern Europe, Germany and the US. More information can be found at http://www.verum.de.

CONTACT:
Antonia Genov
antonia@clearpointagency.com
760-230-2424


'/>"/>
SOURCE Verum.de
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Verum.de Chosen to Provide Clinical Research Services for Oncology Center in Romania
2. Verified Clinical Trials Exhibits at the Annual 2013 Partnerships In Clinical Trials to Discuss the Professional Research Subject and the Clinical Trial Database Registry
3. Patheon Exhibits and Presents at the 2013 IQPC Global Formulation and Drug Delivery Summit
4. Patheon Exhibits at the 2013 Biopharmaceutical Development and Production Week
5. NanoLogix Announces Development of Multi-Well, Rapid Diagnostic Test Variant and Exhibits at the American Society for Microbiology General Meeting in San Francisco
6. Clinovo Sponsors Outsourcing in Clinical Trials Southern California Conference 2013, in La Jolla (CA), September 24-25
7. Clinical Development, Contracts and Outsourcing in MENA & APAC, New Webinar Hosted by Xtalks
8. Clinovo Sponsors the First Outsourcing in Clinical Trials: Medical Devices & Diagnostics Conference, June 12-13, 2013 in Saint Paul, Minnesota
9. DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks
10. Cyber Infrastructure Pvt. Ltd. (CIS) Begins Offering BOT (Build-Operate-Transfer) IT-Outsourcing Model for SMEs
11. Global Healthcare Contract Research Outsourcing Market is expected to reach USD 65.03 billion by 2018: Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology:
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):